{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:21:06Z","timestamp":1773843666859,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.meegid.2018.10.023","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T04:08:15Z","timestamp":1540872495000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Incidence of antiviral drug resistance markers among human influenza A viruses in the Eastern Mediterranean Region, 2005\u20132016"],"prefix":"10.1016","volume":"67","author":[{"given":"Elham","family":"Moasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Moasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-6409","authenticated-orcid":false,"given":"Hassan","family":"Zaraket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.meegid.2018.10.023_bb0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/135965350601100804","article-title":"Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds","volume":"11","author":"Abed","year":"2006","journal-title":"Antivir. Ther."},{"issue":"4","key":"10.1016\/j.meegid.2018.10.023_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2009.01.010","article-title":"Influenza virus shedding\u2014excretion patterns and effects of antiviral treatment","volume":"44","author":"Aoki","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"4 Pt B","key":"10.1016\/j.meegid.2018.10.023_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","article-title":"Influenza virus susceptibility and resistance to oseltamivir","volume":"12","author":"Aoki","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2018.10.023_bb0020","series-title":"Antiviral Chemotherapy 4: New Directions for Clinical Application and Research","first-page":"175","article-title":"Update on therapy of influenza and rhinovirus infections","author":"Arruda","year":"1996"},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.antiviral.2008.06.008","article-title":"Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries","volume":"80","author":"Barr","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2018.10.023_bb0030","series-title":"Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection","author":"Bautista","year":"2010"},{"issue":"6","key":"10.1016\/j.meegid.2018.10.023_bb0035","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/infdis\/159.6.1050","article-title":"Biologic potential of amantadine-resistant influenza A virus in an avian model","volume":"159","author":"Bean","year":"1989","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.meegid.2018.10.023_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/irv.12176","article-title":"Detection and management of antiviral resistance for influenza viruses","volume":"7","author":"Boivin","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"issue":"1","key":"10.1016\/j.meegid.2018.10.023_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","article-title":"The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid","volume":"11","author":"Burmeister","year":"1992","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0050","first-page":"44","article-title":"High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005\u201306 influenza season","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.meegid.2018.10.023_bb0055","author":"Centre for Health Protection"},{"issue":"16","key":"10.1016\/j.meegid.2018.10.023_bb0060","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1128\/JVI.78.16.8609-8614.2004","article-title":"Continuing evolution of H9N2 influenza viruses in Southeastern China","volume":"78","author":"Choi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.10.023_bb0065","series-title":"Seminars in Respiratory and Critical Care Medicine","article-title":"Influenza: epidemiology, clinical features, therapy, and prevention","author":"Clark","year":"2011"},{"issue":"5912","key":"10.1016\/j.meegid.2018.10.023_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2018.10.023_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119115","article-title":"Adamantane-resistant influenza A viruses in the world (1902\u20132013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jiph.2009.04.004","article-title":"Oseltamivir resistance mutation N294S in human influenza A (H5N1) virus in Egypt","volume":"2","author":"Earhart","year":"2009","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.meegid.2018.10.023_bb0090","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1099\/vir.0.063495-0","article-title":"Molecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade","volume":"95","author":"El-Shesheny","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2018.10.023_bb0095","author":"European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.meegid.2018.10.023_bb0100","series-title":"Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","author":"Fiore","year":"2010"},{"issue":"5","key":"10.1016\/j.meegid.2018.10.023_bb0105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"43","key":"10.1016\/j.meegid.2018.10.023_bb0110","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1016\/j.vaccine.2011.08.010","article-title":"Seasonal influenza: the burden of disease in children","volume":"29","author":"Fraaij","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/molbev\/mst204","article-title":"Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors","volume":"31","author":"Garcia","year":"2014","journal-title":"Mol. Biol. Evol."},{"issue":"5937","key":"10.1016\/j.meegid.2018.10.023_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"issue":"28","key":"10.1016\/j.meegid.2018.10.023_bb0125","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1021\/ja1114198","article-title":"Free energy calculations on the two drug binding sites in the M2 proton channel","volume":"133","author":"Gu","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.meegid.2018.10.023_bb0130","series-title":"Advance in Structural Bioinformatics","first-page":"205","article-title":"Drug inhibition and proton conduction mechanisms of the influenza A M2 proton channel","author":"Gu","year":"2015"},{"key":"10.1016\/j.meegid.2018.10.023_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2017.08.004","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015\u20132016","volume":"146","author":"Gubareva","year":"2017","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.meegid.2018.10.023_bb0140","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.meegid.2018.10.023_bb0145","first-page":"119","article-title":"Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine","volume":"176","author":"Hayden","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.meegid.2018.10.023_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.meegid.2018.10.023_bb0155","first-page":"395","article-title":"Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic","volume":"25","author":"Heider","year":"1981","journal-title":"Acta Virol."},{"key":"10.1016\/j.meegid.2018.10.023_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"20","key":"10.1016\/j.meegid.2018.10.023_bb0165","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.meegid.2018.10.023_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A (H1N1) influenza viruses in Oceania, South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antivir. Res."},{"issue":"10","key":"10.1016\/j.meegid.2018.10.023_bb0175","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00334-09","article-title":"In vitro generation of neuraminidase inhibitor resistance in A (H5N1) influenza viruses","volume":"53","author":"Hurt","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"23","key":"10.1016\/j.meegid.2018.10.023_bb0180","doi-asserted-by":"crossref","first-page":"19884","DOI":"10.2807\/ese.16.23.19884-en","article-title":"Increased detection in Australia and Singapore of a novel influenza A (H1N1) 2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation","volume":"16","author":"Hurt","year":"2011","journal-title":"Euro. Surveill."},{"key":"10.1016\/j.meegid.2018.10.023_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2016.06.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014\u20132015","volume":"132","author":"Hurt","year":"2016","journal-title":"Antivir. Res."},{"issue":"47","key":"10.1016\/j.meegid.2018.10.023_bb0190","article-title":"Detection of adamantane-sensitive influenza A (H3N2) viruses in Australia, 2017: a cause for hope?","volume":"22","author":"Hurt","year":"2017","journal-title":"Eur. Secur."},{"key":"10.1016\/j.meegid.2018.10.023_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IDR.S105473","article-title":"Drug resistance in influenza A virus: the epidemiology and management","volume":"10","author":"Hussain","year":"2017","journal-title":"Infect. Drug Resist."},{"issue":"5","key":"10.1016\/j.meegid.2018.10.023_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000933","article-title":"Effect of neuraminidase inhibitor\u2013resistant mutations on pathogenicity of clade 2.2 A\/Turkey\/15\/06 (H5N1) influenza virus in ferrets","volume":"6","author":"Ilyushina","year":"2010","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo","volume":"55","author":"Ives","year":"2002","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.meegid.2018.10.023_bb0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jama.1967.03130060046012","volume":"201","year":"1967","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.meegid.2018.10.023_bb0215","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations","volume":"163","author":"Kaiser","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.meegid.2018.10.023_bb0220","first-page":"187","article-title":"Influenza treatment and prophylaxis with neuraminidase inhibitors: a review","volume":"6","author":"Kamali","year":"2013","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.meegid.2018.10.023_bb0225","series-title":"Insight into Influenza Viruses of Animals and Humans","first-page":"7","article-title":"Properties of influenza viruses","author":"Kapoor","year":"2014"},{"issue":"6","key":"10.1016\/j.meegid.2018.10.023_bb0230","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/irv.12136","article-title":"Influenza research in the Eastern Mediterranean Region: the current state and the way forward","volume":"7","author":"Kayali","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"issue":"3","key":"10.1016\/j.meegid.2018.10.023_bb0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/v10030121","article-title":"Challenge for one health: co-circulation of zoonotic H5N1 and H9N2 avian influenza viruses in Egypt","volume":"10","author":"Kim","year":"2018","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.meegid.2018.10.023_bb0240","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J. Am. Chem. Soc."},{"issue":"9436","key":"10.1016\/j.meegid.2018.10.023_bb0245","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.meegid.2018.10.023_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037095","article-title":"I223R mutation in influenza A (H1N1) pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y","volume":"7","author":"LeGoff","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0255","first-page":"e11","article-title":"Multiple introductions of highly pathogenic avian influenza H5N1 viruses into Bangladesh","volume":"3","author":"Marinova-Petkova","year":"2014","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14656566.3.2.103","article-title":"Neuraminidase inhibitors for the treatment and prevention of influenza","volume":"3","author":"McKimm-Breschkin","year":"2002","journal-title":"Expert. Opin. Pharmacother."},{"issue":"s1","key":"10.1016\/j.meegid.2018.10.023_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"issue":"W1","key":"10.1016\/j.meegid.2018.10.023_bb0270","doi-asserted-by":"crossref","first-page":"W597","DOI":"10.1093\/nar\/gkt376","article-title":"Analysis tool web services from the EMBL-EBI","volume":"41","author":"McWilliam","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2018.10.023_bb0275","series-title":"Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007\u201308 Season","author":"Meijer","year":"2009"},{"issue":"10","key":"10.1016\/j.meegid.2018.10.023_bb0280","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/138955751410141020150822","article-title":"Viral M2 ion channel protein: a promising target for anti-influenza drug discovery","volume":"14","author":"Moorthy","year":"2014","journal-title":"Mini-Rev. Med. Chem."},{"issue":"10","key":"10.1016\/j.meegid.2018.10.023_bb0285","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2018.10.023_bb0290","doi-asserted-by":"crossref","first-page":"813047","DOI":"10.1155\/2015\/813047","article-title":"In silico identification of highly conserved epitopes of influenza A H1N1, H2N2, H3N2, and H5N1 with diagnostic and vaccination potential","volume":"2015","author":"Munoz-Medina","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.meegid.2018.10.023_bb0295","doi-asserted-by":"crossref","first-page":"RRN1126","DOI":"10.1371\/currents.RRN1126","article-title":"The early diversification of influenza A\/H1N1pdm","volume":"1","author":"Nelson","year":"2009","journal-title":"PLoS Curr."},{"issue":"8","key":"10.1016\/j.meegid.2018.10.023_bb0300","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2018.10.023_bb0305","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: who, when, where?","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2018.10.023_bb0310","series-title":"A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade","first-page":"430629","volume":"Vol. 2014","author":"Oh","year":"2014"},{"issue":"1","key":"10.1016\/j.meegid.2018.10.023_bb0315","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2018.10.023_bb0320","series-title":"Fields Virology","article-title":"Orthomyxoviridae: The Viruses and their Replication","author":"Palese","year":"2007"},{"issue":"18","key":"10.1016\/j.meegid.2018.10.023_bb0325","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"Pielak","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.meegid.2018.10.023_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000103","article-title":"Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir","volume":"4","author":"Rameix-Welti","year":"2008","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.meegid.2018.10.023_bb0335","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2018.10.023_bb0340","first-page":"1151","article-title":"Orthomyxoviridae","volume":"2","author":"Shaw","year":"2013","journal-title":"Fields Virol."},{"issue":"1","key":"10.1016\/j.meegid.2018.10.023_bb0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jiq005","article-title":"Dual resistance to adamantanes and oseltamivir among seasonal influenza A (H1N1) viruses: 2008\u20132010","volume":"203","author":"Sheu","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2018.10.023_bb0350","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/IAI.01278-12","article-title":"Influenza-induced inflammation drives pneumococcal otitis media","volume":"81","author":"Short","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2018.10.023_bb0355","author":"The WHO GISRS antiviral susceptibility expert working group (AVWG)"},{"issue":"5","key":"10.1016\/j.meegid.2018.10.023_bb0360","first-page":"10","article-title":"Prodromal symptoms of flu: malaise, rigors, fever and myalgia","volume":"79","author":"Truter","year":"2012","journal-title":"SA Pharm. J."},{"key":"10.1016\/j.meegid.2018.10.023_bb0365","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-405880-4.00006-8","article-title":"Chapter Six \u2013 Influenza virus resistance to antiviral therapy","author":"van der Vries","year":"2013"},{"issue":"7","key":"10.1016\/j.meegid.2018.10.023_bb0370","doi-asserted-by":"crossref","first-page":"e1001053","DOI":"10.1371\/journal.pmed.1001053","article-title":"Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis","volume":"8","author":"Van Kerkhove","year":"2011","journal-title":"PLoS Med."},{"issue":"11","key":"10.1016\/j.meegid.2018.10.023_bb0375","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jama.1981.03310360020016","article-title":"Successful treatment of naturally occurring influenza A\/USSR\/77 H1N1","volume":"245","author":"Van Voris","year":"1981","journal-title":"JAMA"},{"issue":"6428","key":"10.1016\/j.meegid.2018.10.023_bb0380","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.meegid.2018.10.023_bb0385","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.meegid.2018.10.023_bb0390","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki018","article-title":"Oseltamivir (Tamiflu\u00ae) and its potential for use in the event of an influenza pandemic","volume":"55","author":"Ward","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.meegid.2018.10.023_bb0395","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/cis1220","article-title":"Global assessment of resistance to neuraminidase inhibitors, 2008\u20132011: the Influenza Resistance Information Study (IRIS)","volume":"56","author":"Whitley","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.meegid.2018.10.023_bb0400","first-page":"101","article-title":"Recommended composition of influenza virus vaccines for use in the 2013\u20132014 northern hemisphere influenza season","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.meegid.2018.10.023_bb0405","series-title":"Fields Virology","article-title":"Orthomyxoviruses","volume":"Vol. 2","author":"Wright","year":"2007"},{"issue":"17","key":"10.1016\/j.meegid.2018.10.023_bb0410","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"Yen","year":"2006","journal-title":"J. Virol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818305987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818305987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:34:38Z","timestamp":1761575678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134818305987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":82,"alternative-id":["S1567134818305987"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2018.10.023","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of antiviral drug resistance markers among human influenza A viruses in the Eastern Mediterranean Region, 2005\u20132016","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2018.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}